DCGI approves Biological E`s phase 2 and 3 trials of COVID vaccine on children
India's drug regulator granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 and 3 clinical trials on children for its anti-COVID drug called Corbevax.
from Zee News :India National https://ift.tt/3kMHHxF
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour, or randomised words.
0 Comments